Revenue Recognition Segment revenue by major payor (Tables)

3 Months Ended

Mar. 31, 2022

Revenues by major payor [Abstract]

Disaggregation of Revenue [Table Text Block]

The following table summarizes the Company's segment revenues by primary payor source:

	Three months ended March 31, 2022						Three months ended March 31, 2021
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	1,464,086	$		$	1,464,086	$	1,480,297	$		$	1,480,297
Medicaid and Managed Medicaid	189,655				189,655		187,243				187,243
Other government	80,800		116,895		197,695		80,184		106,830		187,014
Commercial	834,579		52,425		887,004		835,479		51,498		886,977
Other revenues:
Medicare and Medicare Advantage			83,596		83,596				85,595		85,595
Medicaid and Managed Medicaid			538		538				300		300
Commercial			1,338		1,338				6,034		6,034
Other(1)	5,976		9,836		15,812		6,675		11,162		17,837
Eliminations of intersegment revenues	(22,169)				(22,169)		(27,003)		(4,293)		(31,296)
Total	$	2,552,927	$	264,628	$	2,817,555	$	2,562,875	$	257,126	$	2,820,001

(1)Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.